panflu Stats

[Mixin]

CS-8958, a long-acting neuraminidase inhibitor (LANI), was discovered by Daiichi Sankyo and is co-owned with Biota Holdings Limited.

CS-8958 is an inhaled formulation for influenza treatment and it is expected that single administration of CS-8958 will be efficacious for the treatment of influenza.

CS-8958 shows efficacy against H5N1 avian influenza virus as well as influenza A and B viruses in preclinical tests.

In this double-blind non-inferiority study, it is expected to confirm that single inhalation of CS-8958 is equally effective to 75 mg of oseltamivir administered orally twice daily for 5 consecutive days. Also, the safety of CS-8958 will be assessed in this study.

http://www.medilexicon.com/medicalnews.php?newsid=129606